Fei Yao | Biochemistry | Best Researcher Award

Prof. Fei Yao | Biochemistry | Best Researcher Award

The First Affiliated Hospital of Guangxi Medical University, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Prof. Fei Yao’s journey in academia began with a strong foundation in biochemistry and medical sciences. With a keen interest in cancer biology, Prof. Yao pursued higher education in oncology, eventually earning a medical degree and further advancing into postdoctoral research. This rigorous academic training laid the groundwork for future contributions to cancer research.

🏥 Professional Endeavors

Currently serving as a Professor of Oncology at The First Affiliated Hospital of Guangxi Medical University, China, and The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Prof. Yao has seamlessly integrated clinical expertise with research innovations. As a medical doctor and postdoctoral fellow, Prof. Yao also mentors master’s students, shaping the next generation of researchers in oncology and biochemistry.

🔬 Contributions and Research Focus

Prof. Yao’s research primarily focuses on tumor microenvironment mechanisms and the development of clinical drugs for cancer treatment. By leading multiple prestigious research projects funded by:

  • 🏅 National Natural Science Foundation of China
  • 🏅 China Postdoctoral Science Foundation
  • 🏅 Guangxi Natural Science Foundation

Prof. Yao has significantly contributed to understanding how cancer cells interact with their surroundings, paving the way for novel therapeutic strategies.

📚 Impact and Influence

Prof. Yao has published multiple SCI-indexed research papers, adding valuable insights to the field of oncology and biochemistry. These studies have not only been widely cited but have also influenced clinical applications and drug development in cancer research.

📖 Academic Citations & Recognition

With a robust research portfolio, Prof. Yao’s work has been cited extensively in international journals, reinforcing its scientific impact. These contributions continue to shape the landscape of cancer treatment and personalized medicine.

🛠️ Technical Skills & Expertise

Prof. Yao possesses expertise in various advanced biochemical and clinical research techniques, including:
✔️ Tumor Microenvironment Analysis
✔️ Cell Culture & Molecular Biology Techniques
✔️ Targeted Drug Development for Cancer
✔️ Clinical Trials & Experimental Therapies
✔️ Biostatistical Analysis & Research Methodologies

🎓 Teaching and Mentorship

As a Master’s Supervisor, Prof. Yao plays a crucial role in mentoring graduate students, guiding them in research methodologies, experimental designs, and thesis development. Many students have benefited from this mentorship, progressing in their careers as medical researchers and clinicians.

🌎 Legacy and Future Contributions

With a deep commitment to advancing cancer research, Prof. Yao aims to:
🔹 Continue exploring innovative treatments targeting the tumor microenvironment.
🔹 Bridge the gap between traditional Chinese medicine and modern oncology.
🔹 Develop next-generation clinical drugs to improve patient outcomes.
🔹 Inspire young researchers to contribute meaningfully to biochemistry and oncology.

🏆 Conclusion

Prof. Fei Yao’s dedication to biochemistry and cancer research has established a remarkable legacy in oncology, drug development, and clinical applications. As an esteemed professor, researcher, and mentor, Prof. Yao’s contributions will continue to impact the field for years to come.

📖Notable Publications

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients

Authors: L. Zhong, L. Gan, B. Wang, W. Shi, Y. Zhao

Journal: Cell

Year: 2025

Duk-Hwa Kwon | Molecular Biology | Best Researcher Award -1610

Dr. Duk-Hwa Kwon | Molecular Biology | Best Researcher Award

Chonnam National University Medical School, South Korea

👨‍🎓Profiles

🎓 Early Academic Pursuits

He began his academic journey in biotechnology, earning his B.S. degree from Chonnam National University, Gwangju, Korea, between 2002 and 2007. Building on his passion for the life sciences, he pursued an M.S. in Biotechnology at the same institution from 2007 to 2009. His early academic endeavors laid a strong foundation in the principles of biological sciences, molecular mechanisms, and biotechnological applications.

🏛️ Professional Endeavors

Following his academic training, He advanced to a Ph.D. in Biomedical Sciences (2011–2014) at Chonnam National University's Medical School. Post-graduation, he transitioned to a postdoctoral fellowship in the Department of Pharmacology at the same university, where he has been serving since 2014. In this role, Dr. Kwon has collaborated on cutting-edge pharmacological research, contributing significantly to the university's academic and scientific reputation.

🔬 Contributions and Research Focus

His research has primarily focused on the intersection of biotechnology and pharmacology. His work has explored molecular mechanisms underlying diseases, drug discovery, and the development of innovative therapeutic strategies. He has contributed to understanding biomedical pathways, significantly advancing pharmacological knowledge and biomedical applications.

🌍 Impact and Influence

His academic and professional contributions have had a profound impact on the fields of biotechnology and pharmacology. By combining foundational biotechnology knowledge with clinical applications, he has addressed critical health challenges, providing innovative solutions to modern medical problems. His work continues to influence the direction of pharmacological research globally.

📚 Academic Citations

As a researcher, He has accumulated a noteworthy number of citations, reflecting the academic community's recognition of his impactful research. His publications have appeared in prestigious journals, marking him as a key contributor to his field.

🛠️ Technical Skills

He possesses advanced technical skills in biotechnology and pharmacology, including molecular biology techniques, drug screening methods, and cell culture systems. His expertise also spans advanced pharmacological modeling and data analysis.

🧑‍🏫 Teaching Experience

In addition to his research roles, He has contributed to academic teaching. His mentorship of students and involvement in laboratory training have helped shape the next generation of researchers and scientists in biotechnology and pharmacology.

🌟 Legacy and Future Contributions

His dedication to biomedical sciences and pharmacology positions him as a leading figure in his field. His legacy lies in his ability to bridge the gap between biotechnology and clinical applications, ensuring that his contributions continue to benefit academia and industry. Looking forward, Dr. Kwon is poised to expand his research into innovative therapies, furthering advancements in healthcare and biomedical science.

📖Notable Publications

MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification

Authors: DH Kwon, GH Eom, JH Ko, S Shin, H Joung, N Choe, YS Nam, HK Min, ...
Journal: Nature Communications
Year: 2016

The microRNA miR‐124 inhibits vascular smooth muscle cell proliferation by targeting S100 calcium‐binding protein A4 (S100A4)

Authors: N Choe, DH Kwon, S Shin, YS Kim, YK Kim, J Kim, Y Ahn, GH Eom, ...
Journal: FEBS Letters
Year: 2017

Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4

Authors: DH Kwon, GH Eom, HJ Kee, YS Nam, YK Cho, DK Kim, JY Koo, HS Kim, ...
Journal: Journal of Molecular and Cellular Cardiology
Year: 2013

Characterization of circular RNAs in vascular smooth muscle cells with vascular calcification

Authors: J Ryu, DH Kwon, N Choe, S Shin, G Jeong, YH Lim, J Kim, WJ Park, ...
Journal: Molecular Therapy-Nucleic Acids
Year: 2020

PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart

Authors: S Yoon, T Kook, HK Min, DH Kwon, YK Cho, M Kim, S Shin, H Joung, ...
Journal: Experimental & Molecular Medicine
Year: 2018

Long noncoding RNAs in vascular smooth muscle cells regulate vascular calcification
Authors: G Jeong, DH Kwon, S Shin, N Choe, J Ryu, YH Lim, J Kim, WJ Park, ...
Journal: Scientific Reports
Year: 2019